<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-id journal-id-type="hwp">ofids</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5781629</article-id><article-id pub-id-type="doi">10.1093/ofid/ofu052.1224</article-id><article-id pub-id-type="publisher-id">ofu052</article-id><article-categories><subj-group subj-group-type="heading"><subject>IDWeek 2014 Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Poster Abstracts</subject></subj-group></subj-group></article-categories><title-group><article-title>1678<break/>Triclosan, triclocarban, metabolism and microbiome: a randomized, cross-over study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pischel</surname><given-names>Lauren</given-names></name><xref ref-type="aff" rid="sa1224-af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Gina A.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="sa1224-af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Haggerty</surname><given-names>Thomas</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="sa1224-af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Ting</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="sa1224-af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Parsonnet</surname><given-names>Julie</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="sa1224-af1">1</xref></contrib></contrib-group><aff id="sa1224-af1"><label>1</label>Stanford University School of Medicine, Stanford, CA</aff><aff id="sa1224-af2"><label>2</label>Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA</aff><aff id="sa1224-af3"><label>3</label>Stanford University, Stanford, CA</aff><author-notes><fn id="TN159" fn-type="con"><p><bold>Session:</bold> 205. Microbial and Host Factors</p></fn><fn id="TN160" fn-type="con"><p>Saturday, October 11, 2014: 12:30 PM</p></fn></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub" iso-8601-date="2014-12-01"><month>12</month><year>2014</year></pub-date><volume>1</volume><issue>Suppl 1</issue><issue-title>IDWeek 2014 Abstracts</issue-title><fpage seq="c">S448</fpage><lpage>S448</lpage><permissions><copyright-statement>&#x000a9; The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America</copyright-statement><copyright-year>2014</copyright-year></permissions><self-uri xlink:href="ofu052.1224.pdf"/></article-meta></front><body><p><bold><italic>Background.</italic></bold>&#x02003;The human microbiome has been implicated in the development and maintenance of obesity. We hypothesized that triclosan and triclocarban(TCS), microbicides found in many household and personal care products (HPCP) and present in 75% of US human urine samples, play a role in altering microbiota, metabolic function and weight.</p><p><bold><italic>Methods.</italic></bold>&#x02003;In a double-blind, randomized, cross-over study participants were given TCS or non-TCS containing toothpaste, dish and hand soap for 4 months then switched arms. Of 16 subjects enrolled, 13 completed the trial. Blood, stool, skin swabs, gingival plaque, saliva, urine samples and weights were obtained at baselineand at regular intervals throughout each period. Bloods were analyzed for metabolic and endocrine markers and urines for TCS. Illumina sequencing of stool skin, skin, saliva and gingival plaque is underway. All statistics were performed in R.</p><p><bold><italic>Results.</italic></bold>&#x02003;In the TCS arm, TC levels where higher (median 25,555 pg/ul) than in the non-TCS arm (median 218 pg/ul) (p &#x0003c; 0.001). No significant differences were found in testosterone, T4 or TSH levels or in 17 adipocytokines on the obesity panel. Six subjects gained more than 0.6% of body weight (the highest quartile) in the TCS arm but lost or stayed at the same weight in the non-TCS arm; the reverse (weight gain in non-TCS but not in TCS arm) was seen in only one person (OR = 6, p = 0.13, McNemar test). Microbiota analysis of saliva, skin and stool samples is pending.</p><p><bold><italic>Conclusion.</italic></bold>&#x02003;In this pilot study we found that individuals were somewhat more likely to gain weight while using TCS-HPCP than when not using TCS-HPCP; this was not explained by hormonal or adipocytokine changes. Sequencing studies will examine whether TCS affects microbial communities.</p><p><bold><italic>Disclosures.</italic></bold>&#x02003;<bold>All authors:</bold> No reported disclosures.</p></body></article>